QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications
Venlo, the Netherlands, Oct. 10, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced key updates […]